ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Hwang S, Park S, Kwon Y. Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol Ther. 2019;199:30–57.
   PubMed Web of Science ®Google Scholar
• Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat. 2009;115(2):423–428. doi:10.1007/s10549-008-0086-2
   PubMed Web of Science ®Google Scholar
• Jiang T, Shi W, Wali VB, et al. Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis. PLoS Med. 2016;13(12):e1002193. doi:10.1371/journal.pmed.1002193
   PubMed Web of Science ®Google Scholar
• Roenneberg T, Merrow M. The circadian clock and human health. Curr Biol. 2016;26(10):R432–R443. doi:10.1016/j.cub.2016.04.011
   PubMed Web of Science ®Google Scholar
• Liu F, Chang H. Physiological links of circadian clock and biological clock of aging. Protein Cell. 2017;8(7):477–488. doi:10.1007/s13238-016-0366-2
   Web of Science ®Google Scholar
• Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017;18(3):164–179. doi:10.1038/nrg.2016.150
   PubMed Web of Science ®Google Scholar
• Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer Lett. 2014;342(1):9–18. doi:10.1016/j.canlet.2013.09.040
   PubMed Web of Science ®Google Scholar
• Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012;18:1249–1260. doi:10.2119/molmed.2012.00077
   PubMed Web of Science ®Google Scholar
• Kettner NM, Katchy CA, Fu L. Circadian gene variants in cancer. Ann Med. 2014;46(4):208–220. doi:10.3109/07853890.2014.914808
   PubMed Web of Science ®Google Scholar
• Reszka E, Przybek M, Muurlink O, Pepłonska B. Circadian gene variants and breast cancer. Cancer Lett. 2017;390:137–145. doi:10.1016/j.canlet.2017.01.012
   PubMed Web of Science ®Google Scholar
• Angelousi A, Kassi E, Ansari-Nasiri N, Randeva H, Kaltsas G, Chrousos G. Clock genes and cancer development in particular in endocrine tissues. Endocr Relat Cancer. 2019;26(6):R305–R317. doi:10.1530/ERC-19-0094
   Web of Science ®Google Scholar
• Blakeman V, Williams JL, Meng Q, Streuli CH. Circadian clocks and breast cancer. Breast Cancer Res. 2016;18(1):89. doi:10.1186/s13058-016-0743-z
   PubMed Web of Science ®Google Scholar
• Chi L, Zou Y, Qin L, et al. TIMELESS contributes to the progression of breast cancer through activation of MYC. Breast Cancer Res. 2017;19(1):53. doi:10.1186/s13058-017-0838-1
   Web of Science ®Google Scholar
• Wang F, Yeung KL, Chan WC, et al. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol. 2013;24(11):2724–2732. doi:10.1093/annonc/mdt283
   PubMed Web of Science ®Google Scholar
• He C, Anand ST, Ebell MH, Vena JE, Robb SW. Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health. 2014;88(5):533–547. doi:10.1007/s00420-014-0986-x
   Web of Science ®Google Scholar
• Van Dycke KCG, Rodenburg W, van Oostrom CTM, et al. Chronically alternating light cycles increase breast cancer risk in mice. Curr Biol. 2015;25(14):1932–1937. doi:10.1016/j.cub.2015.06.012
   PubMed Web of Science ®Google Scholar
• Hadadi E, Taylor W, Li X, et al. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat Commun. 2020;11(1):3117–3193. doi:10.1038/s41467-020-16890-6
   Web of Science ®Google Scholar
• Wang J, Li S, Li X, et al. Circadian protein BMAL1 promotes breast cancer cell invasion and metastasis by up-regulating matrix metalloproteinase 9 expression. Cancer Cell Int. 2019;19(1):112–182.
   Google Scholar
• Lesicka M, Jabłońska E, Wieczorek E, et al. Altered circadian genes expression in breast cancer tissue according to the clinical characteristics. PLoS One. 2018;13(6):e199622. doi:10.1371/journal.pone.0199622
   Web of Science ®Google Scholar
• Xiao L, Chang AK, Zang MX, et al. Induction of the CLOCK gene by E2-ERalpha signaling promotes the proliferation of breast cancer cells. PLoS One. 2014;9(5):e95878. doi:10.1371/journal.pone.0095878
   Web of Science ®Google Scholar
• Oakman C, Viale G, Di Leo A. Management of triple negative breast cancer. Breast. 2010;19(5):312–321. doi:10.1016/j.breast.2010.03.026
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Ukai H, Ueda HR. Systems biology of mammalian circadian clocks. Annu Rev Physiol. 2010;72:579–603. doi:10.1146/annurev-physiol-073109-130051
   PubMed Web of Science ®Google Scholar
• Malorni L, Shetty PB, De Angelis C, et al. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res Treat. 2012;136(3):795–804. doi:10.1007/s10549-012-2315-y
   PubMed Web of Science ®Google Scholar
• Shafi AA, Knudsen KE. Cancer and the circadian clock. Cancer Res. 2019;79(15):3806–3814. doi:10.1158/0008-5472.CAN-19-0566
   PubMed Web of Science ®Google Scholar
• Verlande A, Masri S. Circadian clocks and cancer: timekeeping governs cellular metabolism. Trends Endocrinol Metab. 2019;30(7):445–458. doi:10.1016/j.tem.2019.05.001
   PubMed Web of Science ®Google Scholar
• Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8(12):1065–1066. doi:10.1016/S1470-2045(07)70373-X
   PubMed Web of Science ®Google Scholar
• Ikeda M, Yu W, Hirai M, et al. cDNA cloning of a novel bHLH-PAS transcription factor superfamily gene, BMAL2: its mRNA expression, subcellular distribution, and chromosomal localization. Biochem Biophys Res Commun. 2000;275(2):493–502. doi:10.1006/bbrc.2000.3248
   Web of Science ®Google Scholar
• Brady JJ, Chuang C, Greenside PG, et al. An Arntl2-driven secretome enables lung adenocarcinoma metastatic self-sufficiency. Cancer Cell. 2016;29(5):697–710. doi:10.1016/j.ccell.2016.03.003
   PubMed Web of Science ®Google Scholar
• Lu M, Huang L, Tang Y, et al. ARNTL2 knockdown suppressed the invasion and migration of colon carcinoma: decreased SMOC2-EMT expression through inactivation of PI3K/AKT pathway. Am J Transl Res. 2020;12(4):1293–1308.
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Pazienza V, Panza A, et al. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138(3):501–511. doi:10.1007/s00432-011-1126-6
   PubMed Web of Science ®Google Scholar
• Ha NH, Long J, Cai Q, Shu XO, Hunter KW. The circadian rhythm gene Arntl2 is a metastasis susceptibility gene for estrogen receptor-negative breast cancer. PLoS Genet. 2016;12(9):e1006267. doi:10.1371/journal.pgen.1006267
   PubMed Web of Science ®Google Scholar
• Rida P, Syed MI, Aneja R. Time will tell: circadian clock dysregulation in triple negative breast cancer. Front Biosci. 2019;11:178–192. doi:10.2741/s533
   Google Scholar
• Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690. doi:10.1038/nrclinonc.2016.66
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Busund L, Kilvær TL, et al. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer. J Thorac Oncol. 2016;11(6):789–800. doi:10.1016/j.jtho.2016.01.015
   PubMed Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautès fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717–734. doi:10.1038/nrclinonc.2017.101
   PubMed Web of Science ®Google Scholar
• Scheiermann C, Gibbs J, Ince L, Loudon A. Clocking in to immunity. Nat Rev Immunol. 2018;18(7):423–437. doi:10.1038/s41577-018-0008-4
   PubMed Web of Science ®Google Scholar
• Bass J, Lazar MA. Circadian time signatures of fitness and disease. Science. 2016;354(6315):994–999. doi:10.1126/science.aah4965
   PubMed Web of Science ®Google Scholar
• Scheiermann C, Kunisaki Y, Lucas D, et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity. 2012;37(2):290–301. doi:10.1016/j.immuni.2012.05.021
   PubMed Web of Science ®Google Scholar
• Bellet MM, Deriu E, Liu JZ, et al. Circadian clock regulates the host response to salmonella. Proc Natl Acad Sci. 2013;110(24):9897–9902. doi:10.1073/pnas.1120636110
   PubMed Web of Science ®Google Scholar
• Wang S, Xueyou M, Ying Y, et al. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma. Cancer Cell Int. 2021;21(1):341. doi:10.1186/s12935-021-02046-z
   PubMed Web of Science ®Google Scholar
• Aponte-López A, Fuentes-Pananá EM, Cortes-Muñoz D, Muñoz-Cruz S. Mast cell, the neglected member of the tumor microenvironment: role in breast cancer. J Immunol Res. 2018;2018:1–11. doi:10.1155/2018/2584243
   Web of Science ®Google Scholar
• Qu J, Cheng T, Liu L, et al. Mast cells induce epithelial-to-mesenchymal transition and migration in non-small cell lung cancer through IL-8/Wnt/β-catenin pathway. J Cancer. 2019;10(16):3830–3841. doi:10.7150/jca.29953
   Web of Science ®Google Scholar
• Strouch MJ, Cheon EC, Salabat MR, et al. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res. 2010;16(8):2257–2265. doi:10.1158/1078-0432.CCR-09-1230
   Web of Science ®Google Scholar
• Lu J, Chen XM, Huang HR, et al. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma. Head Neck. 2018;40(6):1245–1253. doi:10.1002/hed.25104
   PubMed Web of Science ®Google Scholar
• Bense RD, Sotiriou C, Piccart-Gebhart MJ, et al. Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer. J Natl Cancer Inst. 2016;109(1):w192. doi:10.1093/jnci/djw192
   Google Scholar
• Lv Y, Zhao Y, Wang X, et al. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-alpha-PD-L1 pathway. J Immunother Cancer. 2019;7(1):54. doi:10.1186/s40425-019-0530-3
   Web of Science ®Google Scholar
• He L, Zhu Z, Chen S, Wang Y, Gu H. Mammary tumor growth and metastasis are reduced in c-Kit mutant sash mice. Cancer Med. 2016;5(6):1292–1297. doi:10.1002/cam4.696
   Web of Science ®Google Scholar
• Jachetti E, Cancila V, Rigoni A, et al. Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer. Cancer Immunol Res. 2018;6(5):552–565. doi:10.1158/2326-6066.CIR-17-0385
   PubMed Web of Science ®Google Scholar
• Shaul ME, Fridlender ZG. Tumor-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16(10):601–620.
   PubMed Web of Science ®Google Scholar
• Jin W, Xu H, Zhang S, et al. Tumor-infiltrating NETs predict postsurgical survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2019;26(2):635–643. doi:10.1245/s10434-018-6941-4
   PubMed Web of Science ®Google Scholar
• Wang J, Bo X, Suo T, et al. Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer. Cancer Sci. 2018;109(7):2266–2274. doi:10.1111/cas.13627
   PubMed Web of Science ®Google Scholar
• Ethier J, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2. doi:10.1186/s13058-016-0794-1
   PubMed Web of Science ®Google Scholar
• Mouchemore KA, Anderson RL, Hamilton JA. Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J. 2018;285(4):665–679. doi:10.1111/febs.14206
   Web of Science ®Google Scholar
• Queen MM, Ryan RE, Holzer RG, Keller-Peck CR, Jorcyk CL. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 2005;65(19):8896–8904.
   PubMed Web of Science ®Google Scholar